news & events
ysios news
08.07.20
VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants
07.07.20
CVRx® Raises $50 Million in New Equity Financing
16.06.20
Ona Therapeutics raises €30M in Series A financing
10.06.20
Ysios Capital presents its third fund of € 200M
04.12.19
Anaconda biomed secures €20 million round of funding
16.07.19
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
26.06.19
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise
02.04.19
Aura Biosciences Completes $40 Million Series D Financing
26.10.18
Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development
26.09.18
Minoryx Therapeutics raises €21.3M in Series B funding round
